Literature DB >> 2871242

Nocturnal adrenal suppression in asthmatic children taking inhaled beclomethasone dipropionate.

C M Law, J L Marchant, J W Honour, M A Preece, J O Warner.   

Abstract

Plasma cortisol was measured every 20 min and sleep was monitored in nineteen asthmatic children, twelve of whom were receiving various doses of inhaled beclomethasone dipropionate (BDP). Children receiving inhaled BDP had lower cortisol secretion during the night than those who were not taking inhaled BDP, a delayed rise from the nocturnal nadir, and low early morning levels. Inhaled BDP produces a dose-dependent adrenal suppression.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2871242     DOI: 10.1016/s0140-6736(86)91045-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  31 in total

1.  Symptomatic adrenal insufficiency presenting with hypoglycaemia in children with asthma receiving high dose inhaled fluticasone propionate.

Authors:  A J Drake; R J Howells; J P H Shield; A Prendiville; P S Ward; E C Crowne
Journal:  BMJ       Date:  2002-05-04

2.  Adrenal insufficiency after treatment with fluticasone. Second line controller treatment might have been tried.

Authors:  Brian J Lipworth
Journal:  BMJ       Date:  2002-10-12

3.  Asthma, inhaled corticosteroid treatment, and growth.

Authors:  T K Ninan; G Russell
Journal:  Arch Dis Child       Date:  1992-06       Impact factor: 3.791

Review 4.  Very high dose inhaled corticosteroids: panacea or poison?

Authors:  G Russell
Journal:  Arch Dis Child       Date:  2006-10       Impact factor: 3.791

Review 5.  Treatment of chronic asthma in children: the changing role of inhaled corticosteroids. Allergy Section, Canadian Paediatric Society.

Authors: 
Journal:  CMAJ       Date:  1991-09-15       Impact factor: 8.262

6.  Review of prescribed treatment for children with asthma in 1990.

Authors:  J O Warner
Journal:  BMJ       Date:  1995-09-09

Review 7.  Therapeutic drug monitoring in the neonate and paediatric age group. Problems and clinical pharmacokinetic implications.

Authors:  J T Gilman
Journal:  Clin Pharmacokinet       Date:  1990-07       Impact factor: 6.447

Review 8.  Adverse effects of inhaled corticosteroids.

Authors:  R J Stead; N J Cooke
Journal:  BMJ       Date:  1989-02-18

Review 9.  Safety of the newer inhaled corticosteroids in childhood asthma.

Authors:  Tabitha L Randell; Kim C Donaghue; Geoffrey R Ambler; Christopher T Cowell; Dominic A Fitzgerald; Peter P van Asperen
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

10.  Treatment of severe steroid dependent preschool asthma with nebulised budesonide suspension.

Authors:  P Ilangovan; S Pedersen; S Godfrey; K Nikander; N Noviski; J O Warner
Journal:  Arch Dis Child       Date:  1993-03       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.